Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated: v3.5.2 added and v3.5.0 removed.
    Difference
    0.0%
    Check dated 2026-04-16T11:11:40.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site revision indicator updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T21:04:53.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated the page revision from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:48:39.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-status notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T03:04:36.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A government funding lapse notice is now displayed on the page, and the site revision tag has been updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:28:54.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Glossary visibility was added and QC-related labels were updated to show the new revision (v3.4.0), replacing the previous version and capitalization variants.
    Difference
    0.2%
    Check dated 2026-01-27T23:54:36.000Z thumbnail image

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.